Retina/Vitreous

Top Story

VIDEO: Lucentis superior to PDT for treating myopic CNVM

November 19, 2017

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Nathan C. Steinle, MD, discusses the RADIANCE trial comparing Lucentis (ranibizumab, Genentech) vs. photodynamic therapy for myopic choroidal neovascular membrane.

Meeting NewsVideo

VIDEO: Luminate after Avastin shows early promise for treating diabetic macular edema

November 18, 2017
NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Baruch D. Kuppermann, MD, PhD, director of the Gavin Herbert Eye Institute at UC Irvine, discusses…
Meeting NewsVideo

VIDEO: Flicker ERG a useful tool for anterior segment surgeons

November 18, 2017
NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Mitchell A. Jackson, MD, discusses how he has implemented flicker ERG as a valuable tool in…
Meeting News

ETDRS, ultra-widefield imaging on par for identifying retinopathy severity

November 17, 2017
NEW ORLEANS — In a baseline data review, ETDRS and ultra-widefield imaging appear comparable for determining diabetic retinopathy severity within the ETDRS fields…
More Headlines »
CME

Best of Retina Forum® 2016 - Diabetic Retinopathy: A Revolution in Treatment Options

This activity is supported by educational grants from Carl Zeiss Meditec, Inc. and Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy (DR) is an insidious, progressive disease. Diabetic macular edema (DME), which can occur at any…
More »
Video
Meeting News

VIDEO: Allegro updates phase 2 studies on Luminate for DME

November 10, 2017
More »
Resource Centers
American Academy of Optometry

American Academy of Optometry

Video
Meeting News

VIDEO: Luminate after Avastin shows early promise for treating diabetic macular edema

November 18, 2017
More »
Advertisement
Advertisement